Commentary: Open access publishing: too much oxygen?BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7494.759 (Published 31 March 2005) Cite this as: BMJ 2005;330:759
- Jeffrey K Aronson, reader in clinical pharmacology ()1
“We hold these truths to be self-evident…” This assertion of the US founding fathers betokened their zeal for human equality and rights. But such an attitude can betoken intellectual arrogance. It was, for example, self evident to paediatricians in the 1950s that it would be beneficial to give premature babies 100% oxygen without proper trial. But 100% oxygen caused blindness, and the balance of benefit to harm was unfavourable.
In their survey of the attitudes of a small sample of scientists to open access1 Schroter and colleagues don't actually trumpet its self evident benefits, but their call for evidence refers to the author pays model, not open access publishing itself, although open access will not be possible without an author pays scheme or something comparable. But scientists' opinions should not frame policy without supporting evidence. We need to ask whether immediate free access to readers, with whatever method of payment is used, would benefit science (not the scientists or the grant giving bodies, who are also zealous about this idea) and hence society. To zealots (“the dream is now achievable”2) the benefits of this 100% oxygen may be self evident. But we have little evidence about the balance of benefits and harms. I believe that the potential advantages are few and the disadvantages many; I have summarised them on bmj.com.
Why should we uncritically adopt this system? We already have a better one, operated by many journals currently and in increasing numbers, in which readers pay for immediate access and access becomes universally free after a delay, for example 12 months, as required by the National Library of Medicine and the Wellcome Trust in their current initiative to digitise back issues of journals. Schemes such as HINARI (Health InterNetwork Access to Research Initiative) and AGORA (Access to Global Online Research in Agriculture) will maximise opportunities to access material that is published in this way.3
In any system the burden of cost should be spread across those who are advantaged. A mixed model might be appropriate, maintaining subscriptions while allowing authors who want or are forced to pay for immediate free access to pay for it, and those who do not want it or cannot afford it, not to. Currently, some journals adopt author pays access, others do not. But there are many more readers than authors, which any balance in funding should reflect.
The uncritical application of basic values is a major source of unforeseen undesirable consequences of social actions.4 Who doesn't instinctively feel that free access on day one is basically desirable? But we need to be completely sure that if we open the tap on the cylinder of this 100% oxygen the benefit to harm balance will be favourable, for we will not be able to turn the tap off—there will be no way back to subscription based journal publishing. As the third author of the above paper1 has written elsewhere, “think harm always.”5
A summary of advantages and disadvantages of the author pays model is on bmj.com.
Competing interests JKA is a fellow of the British Pharmacological Society and chairman of the editorial board of the British Journal of Clinical Pharmacology, which is published on the society's behalf by Blackwell Publishing, as a subscription journal with free access after 12 months; the complete archives of the journal are about to be digitised for free access.